AzTrials
AzTrials

Critically IllONCANCT03249051

Optimization of Nutritional Therapy in Mechanically Ventilated, Critically Ill Patients.

A study testing Indirect Calorimetry in people with Critically Ill, run by University of Hohenheim at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate whether an individualized determination of energy requirements using indirect calorimetry instead of a formula-based approach leads to an optimized nutritional support and as a consequence to an optimized nutritional status of the critically ill, mechanically ventilated patients… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Critically Ill
What is being tested?
Indirect Calorimetry
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteGermany
Study dates
11 Jan 2016to 15 Aug 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Who may be able to join

  • age over 18 years
  • mechanical ventilation
  • an hospital stay of at least three days at the intensive care unit of the University Hospital of Tübingen
  • possibility to perform indirect calorimetry measurements (FiO2 ≤70, PCO2 ≤ 0,5)
  • possibility to perform Bioelectrical Impedance Analysis (BIA)
  • underlying indication for enteral or/and parenteral nutritional support
  • written informed consent from the patient or a legal authorized person

Who cannot join

  • cardiac pacemaker

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University of Hohenheim

    Stuttgart, 70599

Other trials in Germany

About this study

Official title: Optimization of Nutritional Therapy by Variation of Methods to Determine Energy Needs in Mechanically Ventilated, Critically Ill Patients.

The aim of this study is to investigate whether an individualized determination of energy requirements using indirect calorimetry instead of a formula-based approach leads to an optimized nutritional support and as a consequence to an optimized nutritional status of the critically ill, mechanically ventilated patients measured by the phase angle.

Conditions
Critically Ill
Being tested
Indirect Calorimetry
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indirect CalorimetryOther

    Energy need is being determined using indirect Calorimetry

Study groups in NCT03249051
Study groupRoleWhat they receive
Indirect CalorimetryExperimentalThe energy need is being determined by using indirect calorimetry and if necessary, optimized by parenteral, enteral and additive parenteral nutrition.
Receives: Other: Indirect Calorimetry
Standard CareNo interventionThis group receives nutrition supply according to the hospital routine ("standard care")

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Phase angle (PhA)

    The primary endpoint is the change of the phase angle during the stay in the intensive care unit (ICU). A mean difference of 5% is considered as relevant.

    Measured: PhA was measured between one and 90 days (during ICU stay)

Secondary outcomes (4)
  1. Nitrogen Balance

    Difference between intervention and control group between hospital admission and discharge.

    Measured: Nitrogen Balance was measured between one and 90 days (during ICU stay)

  2. Extracellular to body cell mass ratio (ECM/BCM - Ratio)

    Difference between intervention and control group between hospital admission and discharge.

    Measured: ECM/BCM-Ratio was measured between one and 90 days (during ICU stay)

  3. Length of hospital stay in days

    Difference between intervention and control group between hospital admission and discharge.

    Measured: Length of hospital stay was measured between one and 180 days

  4. Length of stay in intensive care unit (ICU) in days

    Difference between intervention and control group between hospital admission and discharge.

    Measured: Length of ICU stay was measured between one and 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2017
  2. Study start11 Jan 2016
  3. Primary completion15 Aug 2017
  4. Study completion15 Aug 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03249051
Sponsor's protocol ID
Indirect Calorimetry in ICU
Acronym
ONCA
Status last verified
Aug 2017
First submitted
25 Jun 2017
Last updated
6 Oct 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Indirect Calorimetry in people with Critically Ill, run by University of Hohenheim at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Phase angle (PhA) (time frame: PhA was measured between one and 90 days (during ICU stay)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in